Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)

ClinicalTrials.gov ID: NCT04712669

Public ClinicalTrials.gov record NCT04712669. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 3:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety and efficacy of Rodatristat Ethyl in pulmonary arterial hypertension (PAH) patients.

Study identification

NCT ID
NCT04712669
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Altavant Sciences GmbH
Industry
Enrollment
108 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 15, 2021 (Actual)
Primary completion
Jun 5, 2023 (Actual)
Completion
Aug 28, 2023 (Actual)
Last update posted
Jun 4, 2025

2021 – 2023

United States locations

U.S. sites
28
U.S. states
20
U.S. cities
26
Facility City State ZIP Site status
Arizona Pulmonary Specialists Phoenix Arizona 85012 —
University of California San Diego Health Sciences La Jolla California 92093 —
VA Greater LA Healthcare System/UCLA Los Angeles California 90073 —
Ronald Reagan UCLA Medical Center Los Angeles California 90095 —
UC Davis Medical Center Sacramento California 95816 —
Jeffrey S. Sager, MD Medical Corporation Santa Barbara California 93105 —
University of Colorado Aurora Colorado 80045 —
George Washington University Medical Center Washington D.C. District of Columbia 20037 —
Mayo Clinic Florida Jacksonville Florida 32224 —
The University of Kansas Medical Center Kansas City Kansas 66160 —
Norton Pulmonary Specialists Louisville Kentucky 40202 —
Tufts Medical Center Boston Massachusetts 02111 —
Brigham and Women's Hospital (BWH), Harvard Medical School Boston Massachusetts 02115 —
University of Michigan Ann Arbor Michigan 48109 —
Mayo Clinic Rochester Minnesota 55905 —
Washington University School of Medicine St Louis Missouri 63110 —
University of New Mexico Heath Science Center Albuquerque New Mexico 87106 —
NYU Langone Health New York New York 10016 —
University of Rochester Rochester New York 14623 —
University of North Carolina Medical Center - Chapel Hill Chapel Hill North Carolina 27514 —
Duke University Medical Center Durham North Carolina 27710 —
University of Cincinnati Physicians Cincinnati Ohio 45219 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
Brown University - Rhode Island Hospital Providence Rhode Island 02903 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
UT Southwestern Dallas Texas 75390 —
Houston Methodist Hospital Houston Texas 77030 —
Inova Fairfax Hospital Falls Church Virginia 22042-3307 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04712669, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2025 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04712669 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →